Does influenza vaccination influence cardiovascular complications?

Expert Review of Cardiovascular Therapy

Volumn 13, Issue 6, 2015, Pages 593-596

  Udell, Jacob A ^a,b,c,d,e   Farkouh, Michael E ^b,c,e   Solomon, Scott D ^f   Vardeny, Orly ^g  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f HARVARD MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

heart failure; influenza; ischemic heart disease; prevention; randomized controlled trial; vaccination

Indexed keywords

INFLUENZA VACCINE;

CARDIOVASCULAR DISEASE; DRUG SAFETY; HEART PROTECTION; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE REACTION; REVIEW; CARDIOVASCULAR DISEASES; COMPLICATION; HOSPITALIZATION; INFLUENZA, HUMAN; PROCEDURES; STATISTICS AND NUMERICAL DATA; VACCINATION; VIROLOGY;

CARDIOVASCULAR DISEASES; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINATION;

EID: 84929916784     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2015.1044439     Document Type: Review

References (18)

1. Mertz D, Kim TH, Johnstone J, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ 2013;347:f5061
2. Sandoval C, Walter SD, Krueger P, et al. Risk of hospitalization during influenza season among a cohort of patients with congestive heart failure. Epidemiol Infect 2007;135(4):574-82
3. Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004;351(25):2611-18
4. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 2009;9(10):601-10
5. Corrales-Medina VF, Alvarez KN, Weissfeld LA, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA 2015;313(3):264-74
6. Paddock CD, Liu L, Denison AM, et al. Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis 2012;205(6):895-905
7. Yende S, DAngelo G, Kellum JA, et al. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 2008;177(11):1242-7
8. Fagnoul D, Pasquier P, Bodson L, et al. Myocardial dysfunction during H1N1 influenza infection. J Crit Care 2013;28(4):321-7
9. Udell JA, Zawi R, Bhatt DL, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 2013; 310(16):1711-20
10. Veljkovic V, Glisic S, Veljkovic N, et al. Influenza vaccine as prevention for cardiovascular diseases: possible molecular mechanism. Vaccine 2014;32(48): 6569-75
11. Bermudez-Fajardo A, Oviedo-Orta E. Influenza vaccination promotes stable atherosclerotic plaques in apoE knockout mice. Atherosclerosis 2011;217(1):97-105
12. Liu WM, van der Zeijst BA, Boog CJ, et al. Aging and impaired immunity to influenza viruses: implications for vaccine development. Hum Vaccin 2011;7(Suppl): 94-8
13. Haq K, McElhaney JE. Immunosenescence: Influenza vaccination and the elderly. Curr Opin Immunol 2014;29:38-42
14. Vardeny O, Sweitzer NK, Detry MA, et al. Decreased immune responses to influenza vaccination in patients with heart failure. J Cardiac Fail 2009;15(4):368-73
15. Keshtkar-Jahromi M, Vakili H, Rahnavardi M, et al. Antibody response to influenza immunization in coronary artery disease patients: a controlled trial. Vaccine 2009;28(1):110-13
16. Van Ermen A, Hermanson MP, Moran JM, et al. Double dose vs. standard dose influenza vaccination in patients with heart failure: a pilot study. Eur J Heart Fail 2013; 15(5):560-4
17. DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014;371(7): 635-45
18. DiazGranados CA, Dunning AJ, Jordanov E, et al. High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009-2010 season. Vaccine 2013;31(6):861-6